Pivot

Changes in the Philippine healthcare industry merit new solutions

Drug Development

Diabetes and Rare Diseases
Immunologic Therapy for Cancer
HIV Vaccine, Dementia, Alzheimers

Healthcare Sector

Increasing healthcare spending
PHP 655B with 10.5% CAGR from 2016-2021
8.2% of Filipinos will be above 60 by end of 2018

Clinical Trial Regulation by 2019

Clinical Trial Regulation by 2019
Mandatory Adverse Event Reporting
Mandatory Phase IV Trials

Who We Are

Incorporated as Pi Health Inc. and registered as a CRO with a License to Operate (LTO) by the Philippine Food and Drug Administration in 2018, PIVOT seeks to address these changes through innovative ways

to increase impactful medical research output of the Philippines on par with advanced countries
to raise the capability and visibility of Filipino Principal Investigators in international journal publications
to contribute to the development of life-changing medications for Filipino patients from all walks of life

Partners